ClearPoint Neuro y UCB firman un acuerdo de licencia para la administración de fármacos de terapia génica
25 mai 2023 08h51 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, California, May 25, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT), una empresa global de plataformas habilitadoras de terapias que ofrecen navegación y administración...
ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
24 mai 2023 09h25 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today...
ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference
18 mai 2023 16h01 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Reports First Quarter 2023 Results
11 mai 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles
10 mai 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023
28 avr. 2023 16h42 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism™ Neuro Laser Therapy System
20 avr. 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model
18 avr. 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil
13 avr. 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
A ClearPoint Neuro Anuncia Aprovação da Carteira de Navegação Neuro pela ANVISA no Brasil
13 avr. 2023 16h05 HE
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Califórnia, April 13, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) (a "Empresa"), uma empresa de plataforma global que fornece navegação e entrega ao cérebro,...